Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Stem cells show promise for hair regrowth, but challenges remain.

More research is needed to find the best long-term treatments for Alopecia Areata.

Immune cells are crucial for hair growth and preventing hair loss.

Upadacitinib may effectively treat alopecia areata without side effects.

Baricitinib successfully treated severe hair loss.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

No cure exists for alopecia areata, and treatments are personalized.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

A woman's hair turned white after taking a cancer drug called dasatinib.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Cetuximab can cause eyelash growth, which is rare but manageable.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.